News
Following the FDA ODD, European designation underscores ICT01’s potential as a novel immunotherapy approach in AML ...
Marseille, France Monday, July 21, 2025, 12:00 Hrs [IST] ...
US$450 million project loan facility secured from new strategic partner Appian Capital Advisory to fund the development and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results